Arbutus Biopharma (ABUS) Short-term Investments (2013 - 2026)
Arbutus Biopharma (ABUS) reported Short-term Investments of $73.45 million for Q2 2026, up 21.1% from $60.68 million a year earlier and up 2.7% from the prior quarter.
Powered by 
Analysis
Arbutus Biopharma (ABUS) Short-term Investments (2013 - 2026) Analysis & Trends
At the end of FY2025, Arbutus Biopharma posted Short-term Investments of $73.46 million, down 14.9% from FY2024.
- Short-term Investments has declined for three consecutive years, though with a five-year compound annual growth rate of 0.7% (FY2020 to FY2025).
- By year, Short-term Investments came in at $86.29 million in FY2024 (-13.5%), $99.72 million in FY2023 (-14.1%), $116.14 million in FY2022 (+152.3%) and $46.04 million in FY2021 (-35.2%).
- Five-year quarterly Short-term Investments spans a low of $43.52 million in Q3 2021 and a high of $125.29 million in Q2 2023.
- Year over year, Short-term Investments gained in 1 of the last eight quarters, with an average decline of 11.5%.
- The high point for year-over-year Short-term Investments in five years was Q3 2022 (growth of 154.4%); the low point was Q2 2024 (a decline of 36.8%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $71.52 million (Q1 2026), $73.46 million (Q4 2025) and $71.29 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Arbutus Biopharma | 944.69 Mn | 571.67 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 73.45 Mn |
| Mar 31, 2026 | 71.52 Mn |
| Dec 31, 2025 | 73.46 Mn |
| Sep 30, 2025 | 71.29 Mn |
| Jun 30, 2025 | 60.68 Mn |
| Mar 31, 2025 | 75.63 Mn |
| Dec 31, 2024 | 86.29 Mn |
| Sep 30, 2024 | 95.95 Mn |
| Jun 30, 2024 | 79.20 Mn |
| Mar 31, 2024 | 86.14 Mn |
| Dec 31, 2023 | 99.72 Mn |
| Sep 30, 2023 | 116.65 Mn |
| Jun 30, 2023 | 125.29 Mn |
| Mar 31, 2023 | 106.15 Mn |
| Dec 31, 2022 | 116.14 Mn |
| Sep 30, 2022 | 110.71 Mn |
| Jun 30, 2022 | 102.88 Mn |
| Mar 31, 2022 | 84.15 Mn |
| Dec 31, 2021 | 46.04 Mn |
| Sep 30, 2021 | 43.52 Mn |
API Access
Arbutus Biopharma Short-term Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=short-term-investments&ticker=ABUS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "short-term-investments", "ticker": "ABUS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=short-term-investments&ticker=ABUS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();